Back to search results

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Abroad (travel likely)Recruiting

Conditions

Hematologic Malignancy · Leukemia · Lymphoma · Acute Lymphocytic Leukemia · ALL · Acute Myelogenous Leukemia · AML · Chronic Myelogenous Leukemia · CML · Myeloproliferative Neoplasm · Non Hodgkin Lymphoma · Hodgkin Lymphoma · Diffuse Large B Cell Lymphoma · Follicular Lymphoma · Burkitt Lymphoma · T-cell Lymphoma · B Cell Lymphoma · Peripheral T Cell Lymphoma · Cutaneous B-Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Children's Hospital Colorado, Aurora, Colorado, United States

    Contact: Study coordinator (Kelly Faulk, MD) · Kelly.Faulk@childrenscolorado.org · (720) 777-5771
    Contact: Principal Investigator (Kelly Faulk, MD)

  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Tasleema Patel) · patelt6@chop.edu · 917-818-6971
    Contact: Principal Investigator (Sarah Tasian, MD)

  • Texas Children's Hospital, Houston, Texas, United States

    Contact: Study coordinator (Michelle Redell, MD) · mlredell@texaschildrens.org · (832) 822-4242
    Contact: Study coordinator (Grace Anand) · gxanand@texaschildrens.org · 832-824-7705

  • Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Kira Mielke) · kmielke@mcw.edu
    Contact: Study coordinator (Kara Nelson) · knelson@mcw.edu
    Contact: Principal Investigator (Michael Burke, MD)
Study leads

  • Lauren Pommert, MD

    Principal Investigator

    Children's Hospital Medical Center, Cincinnati

View source on ClinicalTrials.gov(opens in a new tab)